Keyphrases
Hypoxia
100%
Acute Renal Failure
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Glomerular Hemodynamics
100%
Acute Kidney Injury
40%
Renal Protection
40%
Decline in Kidney Function
40%
Glomerular Pressure
40%
Data Reporting
20%
Clinical High Risk
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Type 2 Diabetic Patients
20%
Suggested Mechanisms
20%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
20%
Hypoxic Injury
20%
Renal Impairment
20%
Acute Disease
20%
Inhibitor Therapy
20%
Inherent Characteristics
20%
Radiocontrast Agents
20%
Reporting Quality
20%
Conflict Data
20%
Concomitant Use
20%
Drug Agents
20%
Safety Outcomes
20%
Tubular Transport
20%
Diuresis
20%
Cardiovascular Protection
20%
Excessive Decline
20%
Medullary Oxygenation
20%
Renal Safety
20%
Volume Depletion
20%
Hemodynamically Unstable
20%
EMPA-REG
20%
Renal Replacement Therapy
20%
Medicine and Dentistry
Hypoxia
100%
Hemodynamic
100%
Acute Kidney Injury
100%
Cotransporter
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Kidney Function
50%
Renal Protection
50%
Drug Therapy
25%
Cardiovascular System
25%
Maturity Onset Diabetes of the Young
25%
Nonsteroid Antiinflammatory Agent
25%
Patient with Type 2 Diabetes
25%
Radiocontrast Agent
25%
Renal Replacement Therapy
25%
Acute Disease
25%
Diuresis
25%
Hypoxic Injury
25%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
25%